These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3697924)

  • 21. Colorectal cancer screening. Faecal occult blood tests.
    McDonald C
    Aust Fam Physician; 1985 Apr; 14(4):273, 276-7. PubMed ID: 4015528
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for colorectal carcinoma in a rural area.
    Heeb MA; Ahlvin RC
    Surgery; 1978 May; 83(5):540-1. PubMed ID: 644446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer screening.
    Applegate WB; Spector MH
    J Community Health; 1981; 7(2):138-51. PubMed ID: 7328198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark.
    Kronborg O; Fenger C; Søndergaard O; Pedersen KM; Olsen J
    Scand J Gastroenterol; 1987 Aug; 22(6):677-86. PubMed ID: 3659830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic validity of fecal occult blood tests for detecting gastroenterological cancers.
    Murakami R; Otani T; Nakanishi K; Fudemoto Y; Ishikawa H; Hiyama T; Tsukuma H; Fujimoto I; Miki N; Oshima A
    Jpn J Cancer Res; 1992 Feb; 83(2):141-5. PubMed ID: 1555995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of a public screening program for colorectal cancer.
    Cummings KM; Michalek A; Tidings J; Herrera L; Mettlin C
    N Y State J Med; 1986 Feb; 86(2):68-72. PubMed ID: 3456526
    [No Abstract]   [Full Text] [Related]  

  • 28. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia.
    Winawer SJ; Fleisher M
    Gastroenterology; 1982 May; 82(5 Pt 1):986-91. PubMed ID: 7060917
    [No Abstract]   [Full Text] [Related]  

  • 30. [Screening for colorectal cancer based on our experience with early colorectal cancer and adenoma].
    Miyazaki I; Takashima S; Takigawa Y; Kosaka T; Ueno K
    Gan No Rinsho; 1985 Jan; 31(1):52-6. PubMed ID: 3981802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
    Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal occult blood screening in northern Idaho.
    Raine M; LaVigne R
    J Fam Pract; 1987 Dec; 25(6):611-2. PubMed ID: 3681225
    [No Abstract]   [Full Text] [Related]  

  • 33. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
    Yu H
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occult-blood screening for colorectal carcinoma: the yield and the costs.
    Frank JW
    Am J Prev Med; 1985; 1(5):18-24. PubMed ID: 3939711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of a cancer registry in a mass screening program for colorectal cancer.
    Michalek AM; Cummings KM; Gamble D
    Cancer Detect Prev; 1988; 11(3-6):353-7. PubMed ID: 3390856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pros and cons of fecal occult blood testing for colorectal neoplasms.
    Simon JB
    Cancer Metastasis Rev; 1987; 6(3):397-411. PubMed ID: 3319274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for colorectal cancer in a high-risk population. Results of a mathematical model.
    Eddy DM; Nugent FW; Eddy JF; Coller J; Gilbertsen V; Gottlieb LS; Rice R; Sherlock P; Winawer S
    Gastroenterology; 1987 Mar; 92(3):682-92. PubMed ID: 3102307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.
    Windeler J; Köbberling J
    Int J Colorectal Dis; 1987 Nov; 2(4):223-8. PubMed ID: 3320232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.